Cargando…
Programmed Cell Death-Ligand 1 Expression Status in Urothelial Carcinoma According to Clinical and Pathological Factors: A Multi-Institutional Retrospective Study
Purpose: To investigate programmed cell death-ligand 1 (PD-L1) expression status and the clinical and pathological factors related to its expression in urothelial carcinoma (UC) patients. Materials and Methods: Data from 761 UC patients who underwent testing for PD-L1 expression using the VENTANA (S...
Autores principales: | Kim, Hyung Suk, Jang, Won Sik, Ham, Won Sik, Jung, Seung Il, Lee, Dong Hyun, Ku, Ja Hyeon, Ha, Hong Koo, Ku, Ja Yoon, Choi, Se Young, Chang, In Ho, Choi, Taesoo, Song, Wan, Jeon, Seong Soo, Jeong, Byong Chang, Kim, Sung Han, Seo, Ho Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562813/ https://www.ncbi.nlm.nih.gov/pubmed/33134169 http://dx.doi.org/10.3389/fonc.2020.568809 |
Ejemplares similares
-
Second-Line Systemic Treatment for Metastatic Urothelial Carcinoma: A Network Meta-Analysis of Randomized Phase III Clinical Trials
por: Yoon, Hyun Sik, et al.
Publicado: (2019) -
Current status of the focused series “Urothelial Carcinoma”
por: Yuk, Hyeong Dong, et al.
Publicado: (2020) -
Conditional Survival and Associated Prognostic Factors in Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy: A Retrospective Study at a Single Institution
por: Kang, Minyong, et al.
Publicado: (2016) -
The Comparison of Oncologic Outcomes between Open and Laparoscopic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Korean Multicenter Collaborative Study
por: Kim, Tae Heon, et al.
Publicado: (2019) -
Editorial: Recent Advances in Diagnosis and Management of Urothelial Carcinoma
por: Ku, Ja Hyeon, et al.
Publicado: (2021)